nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—Gemcitabine—breast cancer	0.311	1	CrCtD
Lamivudine—NME1—breast cancer	0.122	0.63	CbGaD
Lamivudine—Zalcitabine—Gemcitabine—breast cancer	0.0823	0.522	CrCrCtD
Lamivudine—CMPK1—Gemcitabine—breast cancer	0.0514	0.254	CbGbCtD
Lamivudine—ABCC1—breast cancer	0.0409	0.212	CbGaD
Lamivudine—Cytarabine—Gemcitabine—breast cancer	0.0395	0.251	CrCrCtD
Lamivudine—Decitabine—Gemcitabine—breast cancer	0.0358	0.227	CrCrCtD
Lamivudine—ABCG2—breast cancer	0.0216	0.112	CbGaD
Lamivudine—SLC22A3—Melphalan—breast cancer	0.0169	0.0835	CbGbCtD
Lamivudine—DCK—Gemcitabine—breast cancer	0.0131	0.0651	CbGbCtD
Lamivudine—ABCC1—Idarubicin—breast cancer	0.011	0.0545	CbGbCtD
Lamivudine—ABCB1—breast cancer	0.00897	0.0464	CbGaD
Lamivudine—ABCC3—Fluorouracil—breast cancer	0.00583	0.0289	CbGbCtD
Lamivudine—SLC22A3—Irinotecan—breast cancer	0.00571	0.0283	CbGbCtD
Lamivudine—ABCC1—Mitoxantrone—breast cancer	0.00474	0.0234	CbGbCtD
Lamivudine—ABCC4—Fluorouracil—breast cancer	0.00445	0.022	CbGbCtD
Lamivudine—ABCC1—Epirubicin—breast cancer	0.00383	0.019	CbGbCtD
Lamivudine—ABCC1—Paclitaxel—breast cancer	0.00378	0.0187	CbGbCtD
Lamivudine—ABCC1—Irinotecan—breast cancer	0.00373	0.0185	CbGbCtD
Lamivudine—ABCC2—Tamoxifen—breast cancer	0.0036	0.0178	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—breast cancer	0.00332	0.0164	CbGbCtD
Lamivudine—ABCC1—Vinblastine—breast cancer	0.00332	0.0164	CbGbCtD
Lamivudine—ABCG2—Tamoxifen—breast cancer	0.00325	0.0161	CbGbCtD
Lamivudine—ABCC3—Methotrexate—breast cancer	0.00321	0.0159	CbGbCtD
Lamivudine—ABCB1—Toremifene—breast cancer	0.00321	0.0159	CbGbCtD
Lamivudine—ABCG2—Mitoxantrone—breast cancer	0.00317	0.0157	CbGbCtD
Lamivudine—SLC22A2—Vinblastine—breast cancer	0.00301	0.0149	CbGbCtD
Lamivudine—ABCC2—Paclitaxel—breast cancer	0.0028	0.0139	CbGbCtD
Lamivudine—ABCC2—Irinotecan—breast cancer	0.00276	0.0137	CbGbCtD
Lamivudine—ABCC1—Docetaxel—breast cancer	0.00273	0.0135	CbGbCtD
Lamivudine—ABCC2—Carboplatin—breast cancer	0.00263	0.013	CbGbCtD
Lamivudine—ABCG2—Paclitaxel—breast cancer	0.00253	0.0125	CbGbCtD
Lamivudine—ABCG2—Irinotecan—breast cancer	0.0025	0.0124	CbGbCtD
Lamivudine—ABCC4—Methotrexate—breast cancer	0.00246	0.0122	CbGbCtD
Lamivudine—ABCC2—Vinblastine—breast cancer	0.00245	0.0121	CbGbCtD
Lamivudine—ABCG2—Fluorouracil—breast cancer	0.0024	0.0119	CbGbCtD
Lamivudine—ABCG2—Carboplatin—breast cancer	0.00238	0.0118	CbGbCtD
Lamivudine—ABCB1—Lapatinib—breast cancer	0.00234	0.0116	CbGbCtD
Lamivudine—ABCC1—Doxorubicin—breast cancer	0.00204	0.0101	CbGbCtD
Lamivudine—ABCC2—Docetaxel—breast cancer	0.00202	0.01	CbGbCtD
Lamivudine—ABCC1—Methotrexate—breast cancer	0.00197	0.00977	CbGbCtD
Lamivudine—ABCG2—Docetaxel—breast cancer	0.00183	0.00905	CbGbCtD
Lamivudine—ABCC2—Doxorubicin—breast cancer	0.00151	0.00747	CbGbCtD
Lamivudine—ABCC2—Methotrexate—breast cancer	0.00146	0.00723	CbGbCtD
Lamivudine—ABCG2—Doxorubicin—breast cancer	0.00136	0.00675	CbGbCtD
Lamivudine—ABCG2—Methotrexate—breast cancer	0.00132	0.00654	CbGbCtD
Lamivudine—ABCB1—Vinorelbine—breast cancer	0.0013	0.00643	CbGbCtD
Lamivudine—ABCB1—Tamoxifen—breast cancer	0.00117	0.0058	CbGbCtD
Lamivudine—ABCB1—Mitoxantrone—breast cancer	0.00114	0.00566	CbGbCtD
Lamivudine—SLC22A6—Methotrexate—breast cancer	0.00107	0.00529	CbGbCtD
Lamivudine—ABCB1—Gemcitabine—breast cancer	0.00101	0.005	CbGbCtD
Lamivudine—ABCB1—Paclitaxel—breast cancer	0.000912	0.00452	CbGbCtD
Lamivudine—ABCB1—Irinotecan—breast cancer	0.0009	0.00445	CbGbCtD
Lamivudine—ABCB1—Vinblastine—breast cancer	0.0008	0.00396	CbGbCtD
Lamivudine—PGK1—skin of body—breast cancer	0.000676	0.0296	CbGeAlD
Lamivudine—ABCB1—Docetaxel—breast cancer	0.00066	0.00326	CbGbCtD
Lamivudine—PCYT2—female reproductive system—breast cancer	0.000615	0.0269	CbGeAlD
Lamivudine—PGK1—uterus—breast cancer	0.000588	0.0257	CbGeAlD
Lamivudine—PGK1—female reproductive system—breast cancer	0.000528	0.0231	CbGeAlD
Lamivudine—PCYT2—endocrine gland—breast cancer	0.00052	0.0227	CbGeAlD
Lamivudine—NT5C—uterus—breast cancer	0.000496	0.0217	CbGeAlD
Lamivudine—ABCB1—Doxorubicin—breast cancer	0.000492	0.00243	CbGbCtD
Lamivudine—NT5C—pituitary gland—breast cancer	0.000487	0.0213	CbGeAlD
Lamivudine—NT5C—adipose tissue—breast cancer	0.000485	0.0212	CbGeAlD
Lamivudine—NME1-NME2—female reproductive system—breast cancer	0.000481	0.021	CbGeAlD
Lamivudine—ABCB1—Methotrexate—breast cancer	0.000476	0.00236	CbGbCtD
Lamivudine—Gemcitabine—SLC28A1—breast cancer	0.000449	0.252	CrCbGaD
Lamivudine—PGK1—endocrine gland—breast cancer	0.000447	0.0195	CbGeAlD
Lamivudine—NT5C—female reproductive system—breast cancer	0.000446	0.0195	CbGeAlD
Lamivudine—NT5C—adrenal gland—breast cancer	0.000435	0.019	CbGeAlD
Lamivudine—NME2—embryo—breast cancer	0.000435	0.019	CbGeAlD
Lamivudine—PCYT1A—female reproductive system—breast cancer	0.000419	0.0183	CbGeAlD
Lamivudine—NME1-NME2—endocrine gland—breast cancer	0.000407	0.0178	CbGeAlD
Lamivudine—NT5C—female gonad—breast cancer	0.000406	0.0177	CbGeAlD
Lamivudine—Decitabine—DNMT3A—breast cancer	0.000397	0.223	CrCbGaD
Lamivudine—NT5C—endocrine gland—breast cancer	0.000377	0.0165	CbGeAlD
Lamivudine—NME1—skin of body—breast cancer	0.000358	0.0157	CbGeAlD
Lamivudine—NME2—epithelium—breast cancer	0.000355	0.0155	CbGeAlD
Lamivudine—PCYT1A—endocrine gland—breast cancer	0.000354	0.0155	CbGeAlD
Lamivudine—CMPK1—skin of body—breast cancer	0.000345	0.0151	CbGeAlD
Lamivudine—NME1—uterus—breast cancer	0.000311	0.0136	CbGeAlD
Lamivudine—NME1—Gefitinib—Lapatinib—breast cancer	0.000308	0.303	CbGdCrCtD
Lamivudine—NME1—adipose tissue—breast cancer	0.000304	0.0133	CbGeAlD
Lamivudine—Gemcitabine—CDA—breast cancer	0.000303	0.17	CrCbGaD
Lamivudine—CMPK1—uterus—breast cancer	0.0003	0.0131	CbGeAlD
Lamivudine—CMPK1—pituitary gland—breast cancer	0.000295	0.0129	CbGeAlD
Lamivudine—CMPK1—adipose tissue—breast cancer	0.000293	0.0128	CbGeAlD
Lamivudine—NME2—adipose tissue—breast cancer	0.000287	0.0125	CbGeAlD
Lamivudine—NME1-NME2—lymph node—breast cancer	0.000281	0.0123	CbGeAlD
Lamivudine—NME1—female reproductive system—breast cancer	0.00028	0.0122	CbGeAlD
Lamivudine—NME1—adrenal gland—breast cancer	0.000273	0.0119	CbGeAlD
Lamivudine—CMPK1—female reproductive system—breast cancer	0.00027	0.0118	CbGeAlD
Lamivudine—DCK—nipple—breast cancer	0.000268	0.0117	CbGeAlD
Lamivudine—NME1—bone marrow—breast cancer	0.000264	0.0115	CbGeAlD
Lamivudine—NME2—female reproductive system—breast cancer	0.000264	0.0115	CbGeAlD
Lamivudine—CMPK1—adrenal gland—breast cancer	0.000263	0.0115	CbGeAlD
Lamivudine—NT5C—lymph node—breast cancer	0.000261	0.0114	CbGeAlD
Lamivudine—NME2—adrenal gland—breast cancer	0.000257	0.0112	CbGeAlD
Lamivudine—NME1—female gonad—breast cancer	0.000255	0.0111	CbGeAlD
Lamivudine—CMPK1—bone marrow—breast cancer	0.000255	0.0111	CbGeAlD
Lamivudine—CMPK1—female gonad—breast cancer	0.000245	0.0107	CbGeAlD
Lamivudine—NME2—female gonad—breast cancer	0.00024	0.0105	CbGeAlD
Lamivudine—NME1—endocrine gland—breast cancer	0.000237	0.0104	CbGeAlD
Lamivudine—CMPK1—endocrine gland—breast cancer	0.000228	0.00997	CbGeAlD
Lamivudine—NME2—endocrine gland—breast cancer	0.000223	0.00975	CbGeAlD
Lamivudine—DCK—embryo—breast cancer	0.000222	0.00968	CbGeAlD
Lamivudine—SLC22A3—nipple—breast cancer	0.000219	0.00956	CbGeAlD
Lamivudine—Decitabine—DNMT1—breast cancer	0.000214	0.12	CrCbGaD
Lamivudine—Cytarabine—CDA—breast cancer	0.000207	0.116	CrCbGaD
Lamivudine—ABCC1—nipple—breast cancer	0.000181	0.00791	CbGeAlD
Lamivudine—SLC22A3—embryo—breast cancer	0.000181	0.00789	CbGeAlD
Lamivudine—NME1—lymph node—breast cancer	0.000164	0.00715	CbGeAlD
Lamivudine—DCK—endometrium—breast cancer	0.000162	0.00709	CbGeAlD
Lamivudine—CMPK1—lymph node—breast cancer	0.000158	0.0069	CbGeAlD
Lamivudine—NME2—lymph node—breast cancer	0.000154	0.00674	CbGeAlD
Lamivudine—DCK—Topotecan—Irinotecan—breast cancer	0.000152	0.15	CbGdCrCtD
Lamivudine—DCK—uterus—breast cancer	0.000149	0.00653	CbGeAlD
Lamivudine—DCK—pituitary gland—breast cancer	0.000147	0.00641	CbGeAlD
Lamivudine—DCK—adipose tissue—breast cancer	0.000146	0.00639	CbGeAlD
Lamivudine—ABCC3—adipose tissue—breast cancer	0.00014	0.00611	CbGeAlD
Lamivudine—DCK—female reproductive system—breast cancer	0.000134	0.00587	CbGeAlD
Lamivudine—SLC22A3—endometrium—breast cancer	0.000132	0.00577	CbGeAlD
Lamivudine—DCK—adrenal gland—breast cancer	0.000131	0.00573	CbGeAlD
Lamivudine—ABCC3—female reproductive system—breast cancer	0.000129	0.00562	CbGeAlD
Lamivudine—DCK—bone marrow—breast cancer	0.000127	0.00554	CbGeAlD
Lamivudine—ABCC3—adrenal gland—breast cancer	0.000125	0.00548	CbGeAlD
Lamivudine—SLC22A1—adipose tissue—breast cancer	0.000125	0.00545	CbGeAlD
Lamivudine—DCK—female gonad—breast cancer	0.000122	0.00534	CbGeAlD
Lamivudine—SLC22A3—adipose tissue—breast cancer	0.000119	0.0052	CbGeAlD
Lamivudine—ABCC4—uterus—breast cancer	0.000118	0.00516	CbGeAlD
Lamivudine—ABCC3—female gonad—breast cancer	0.000117	0.00511	CbGeAlD
Lamivudine—ABCC4—adipose tissue—breast cancer	0.000115	0.00505	CbGeAlD
Lamivudine—DCK—endocrine gland—breast cancer	0.000114	0.00497	CbGeAlD
Lamivudine—SLC22A3—female reproductive system—breast cancer	0.000109	0.00478	CbGeAlD
Lamivudine—ABCC1—endometrium—breast cancer	0.000109	0.00477	CbGeAlD
Lamivudine—ABCC3—endocrine gland—breast cancer	0.000109	0.00476	CbGeAlD
Lamivudine—SLC22A3—adrenal gland—breast cancer	0.000107	0.00467	CbGeAlD
Lamivudine—ABCC4—female reproductive system—breast cancer	0.000106	0.00464	CbGeAlD
Lamivudine—ABCC4—adrenal gland—breast cancer	0.000104	0.00453	CbGeAlD
Lamivudine—ABCC2—female reproductive system—breast cancer	0.000103	0.00449	CbGeAlD
Lamivudine—NME1—Loperamide—Toremifene—breast cancer	0.000103	0.101	CbGdCrCtD
Lamivudine—ABCC1—uterus—breast cancer	0.000101	0.0044	CbGeAlD
Lamivudine—ABCC2—adrenal gland—breast cancer	0.0001	0.00438	CbGeAlD
Lamivudine—ABCC4—bone marrow—breast cancer	0.0001	0.00438	CbGeAlD
Lamivudine—SLC22A3—female gonad—breast cancer	9.96e-05	0.00435	CbGeAlD
Lamivudine—ABCC1—pituitary gland—breast cancer	9.89e-05	0.00432	CbGeAlD
Lamivudine—Gemcitabine—TYMS—breast cancer	9.88e-05	0.0555	CrCbGaD
Lamivudine—ABCC1—adipose tissue—breast cancer	9.84e-05	0.0043	CbGeAlD
Lamivudine—SLC22A1—endocrine gland—breast cancer	9.69e-05	0.00424	CbGeAlD
Lamivudine—ABCC4—female gonad—breast cancer	9.66e-05	0.00422	CbGeAlD
Lamivudine—SLC22A3—endocrine gland—breast cancer	9.26e-05	0.00405	CbGeAlD
Lamivudine—ABCG2—endometrium—breast cancer	9.04e-05	0.00395	CbGeAlD
Lamivudine—ABCC4—endocrine gland—breast cancer	8.98e-05	0.00393	CbGeAlD
Lamivudine—ABCC1—adrenal gland—breast cancer	8.83e-05	0.00386	CbGeAlD
Lamivudine—ABCC2—endocrine gland—breast cancer	8.69e-05	0.0038	CbGeAlD
Lamivudine—ABCG2—uterus—breast cancer	8.33e-05	0.00364	CbGeAlD
Lamivudine—ABCC1—female gonad—breast cancer	8.23e-05	0.0036	CbGeAlD
Lamivudine—ABCG2—pituitary gland—breast cancer	8.18e-05	0.00358	CbGeAlD
Lamivudine—ABCG2—adipose tissue—breast cancer	8.15e-05	0.00356	CbGeAlD
Lamivudine—DCK—lymph node—breast cancer	7.86e-05	0.00343	CbGeAlD
Lamivudine—DCK—Epirubicin—Idarubicin—breast cancer	7.79e-05	0.0765	CbGdCrCtD
Lamivudine—DCK—Doxorubicin—Idarubicin—breast cancer	7.79e-05	0.0765	CbGdCrCtD
Lamivudine—ABCC3—lymph node—breast cancer	7.52e-05	0.00329	CbGeAlD
Lamivudine—DCK—Clomifene—Toremifene—breast cancer	7.46e-05	0.0733	CbGdCrCtD
Lamivudine—ABCG2—adrenal gland—breast cancer	7.31e-05	0.0032	CbGeAlD
Lamivudine—ABCG2—bone marrow—breast cancer	7.07e-05	0.00309	CbGeAlD
Lamivudine—ABCG2—female gonad—breast cancer	6.82e-05	0.00298	CbGeAlD
Lamivudine—NME1—Loperamide—Tamoxifen—breast cancer	6.45e-05	0.0634	CbGdCrCtD
Lamivudine—SLC22A3—lymph node—breast cancer	6.4e-05	0.0028	CbGeAlD
Lamivudine—ABCC4—lymph node—breast cancer	6.21e-05	0.00271	CbGeAlD
Lamivudine—ABCB1—embryo—breast cancer	6.09e-05	0.00266	CbGeAlD
Lamivudine—ABCC2—lymph node—breast cancer	6.01e-05	0.00263	CbGeAlD
Lamivudine—ABCC1—lymph node—breast cancer	5.29e-05	0.00231	CbGeAlD
Lamivudine—ABCB1—epithelium—breast cancer	4.97e-05	0.00217	CbGeAlD
Lamivudine—DCK—Clomifene—Tamoxifen—breast cancer	4.68e-05	0.046	CbGdCrCtD
Lamivudine—ABCB1—endometrium—breast cancer	4.46e-05	0.00195	CbGeAlD
Lamivudine—DCK—Desoximetasone—Fluoxymesterone—breast cancer	4.38e-05	0.0431	CbGdCrCtD
Lamivudine—ABCG2—lymph node—breast cancer	4.38e-05	0.00192	CbGeAlD
Lamivudine—ABCB1—uterus—breast cancer	4.11e-05	0.0018	CbGeAlD
Lamivudine—ABCB1—pituitary gland—breast cancer	4.04e-05	0.00176	CbGeAlD
Lamivudine—ABCB1—adipose tissue—breast cancer	4.02e-05	0.00176	CbGeAlD
Lamivudine—ABCB1—female reproductive system—breast cancer	3.69e-05	0.00161	CbGeAlD
Lamivudine—ABCB1—adrenal gland—breast cancer	3.61e-05	0.00158	CbGeAlD
Lamivudine—DCK—Doxorubicin—Epirubicin—breast cancer	3.58e-05	0.0351	CbGdCrCtD
Lamivudine—Zalcitabine—CYP2D6—breast cancer	3.56e-05	0.02	CrCbGaD
Lamivudine—ABCB1—bone marrow—breast cancer	3.49e-05	0.00152	CbGeAlD
Lamivudine—ABCB1—female gonad—breast cancer	3.36e-05	0.00147	CbGeAlD
Lamivudine—DCK—Epirubicin—Doxorubicin—breast cancer	3.31e-05	0.0325	CbGdCrCtD
Lamivudine—ABCB1—endocrine gland—breast cancer	3.13e-05	0.00137	CbGeAlD
Lamivudine—Zalcitabine—CYP3A4—breast cancer	3.06e-05	0.0172	CrCbGaD
Lamivudine—Gemcitabine—ABCB1—breast cancer	2.5e-05	0.0141	CrCbGaD
Lamivudine—ABCB1—lymph node—breast cancer	2.16e-05	0.000945	CbGeAlD
Lamivudine—Cytarabine—CYP3A4—breast cancer	2.05e-05	0.0115	CrCbGaD
Lamivudine—Malnutrition—Methotrexate—breast cancer	1.03e-05	0.000171	CcSEcCtD
Lamivudine—Erythema—Methotrexate—breast cancer	1.03e-05	0.000171	CcSEcCtD
Lamivudine—Headache—Gemcitabine—breast cancer	1.03e-05	0.000171	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Capecitabine—breast cancer	1.03e-05	0.000171	CcSEcCtD
Lamivudine—Vomiting—Fluorouracil—breast cancer	1.03e-05	0.000171	CcSEcCtD
Lamivudine—Rhinitis—Doxorubicin—breast cancer	1.03e-05	0.00017	CcSEcCtD
Lamivudine—Dyspepsia—Docetaxel—breast cancer	1.03e-05	0.00017	CcSEcCtD
Lamivudine—Hepatitis—Doxorubicin—breast cancer	1.02e-05	0.00017	CcSEcCtD
Lamivudine—Insomnia—Capecitabine—breast cancer	1.02e-05	0.00017	CcSEcCtD
Lamivudine—Hypoaesthesia—Doxorubicin—breast cancer	1.02e-05	0.000169	CcSEcCtD
Lamivudine—Rash—Fluorouracil—breast cancer	1.02e-05	0.000169	CcSEcCtD
Lamivudine—Dermatitis—Fluorouracil—breast cancer	1.02e-05	0.000169	CcSEcCtD
Lamivudine—Pharyngitis—Doxorubicin—breast cancer	1.02e-05	0.000169	CcSEcCtD
Lamivudine—Paraesthesia—Capecitabine—breast cancer	1.01e-05	0.000168	CcSEcCtD
Lamivudine—Decreased appetite—Docetaxel—breast cancer	1.01e-05	0.000168	CcSEcCtD
Lamivudine—Hypersensitivity—Paclitaxel—breast cancer	1.01e-05	0.000168	CcSEcCtD
Lamivudine—Headache—Fluorouracil—breast cancer	1.01e-05	0.000168	CcSEcCtD
Lamivudine—Dysgeusia—Methotrexate—breast cancer	1.01e-05	0.000167	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Docetaxel—breast cancer	1.01e-05	0.000167	CcSEcCtD
Lamivudine—Connective tissue disorder—Doxorubicin—breast cancer	1.01e-05	0.000167	CcSEcCtD
Lamivudine—Dyspnoea—Capecitabine—breast cancer	1.01e-05	0.000167	CcSEcCtD
Lamivudine—Fatigue—Docetaxel—breast cancer	1e-05	0.000167	CcSEcCtD
Lamivudine—Nausea—Irinotecan—breast cancer	1e-05	0.000166	CcSEcCtD
Lamivudine—Nausea—Mitoxantrone—breast cancer	1e-05	0.000166	CcSEcCtD
Lamivudine—Immune system disorder—Epirubicin—breast cancer	9.99e-06	0.000166	CcSEcCtD
Lamivudine—Mediastinal disorder—Epirubicin—breast cancer	9.97e-06	0.000166	CcSEcCtD
Lamivudine—Pain—Docetaxel—breast cancer	9.96e-06	0.000166	CcSEcCtD
Lamivudine—Constipation—Docetaxel—breast cancer	9.96e-06	0.000166	CcSEcCtD
Lamivudine—Back pain—Methotrexate—breast cancer	9.95e-06	0.000165	CcSEcCtD
Lamivudine—Dyspepsia—Capecitabine—breast cancer	9.93e-06	0.000165	CcSEcCtD
Lamivudine—Chills—Epirubicin—breast cancer	9.92e-06	0.000165	CcSEcCtD
Lamivudine—Asthenia—Paclitaxel—breast cancer	9.86e-06	0.000164	CcSEcCtD
Lamivudine—Decreased appetite—Capecitabine—breast cancer	9.8e-06	0.000163	CcSEcCtD
Lamivudine—Alopecia—Epirubicin—breast cancer	9.77e-06	0.000162	CcSEcCtD
Lamivudine—Nausea—Gemcitabine—breast cancer	9.75e-06	0.000162	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Capecitabine—breast cancer	9.74e-06	0.000162	CcSEcCtD
Lamivudine—Fatigue—Capecitabine—breast cancer	9.72e-06	0.000162	CcSEcCtD
Lamivudine—Pruritus—Paclitaxel—breast cancer	9.72e-06	0.000162	CcSEcCtD
Lamivudine—Erythema multiforme—Doxorubicin—breast cancer	9.67e-06	0.000161	CcSEcCtD
Lamivudine—Pain—Capecitabine—breast cancer	9.64e-06	0.00016	CcSEcCtD
Lamivudine—Constipation—Capecitabine—breast cancer	9.64e-06	0.00016	CcSEcCtD
Lamivudine—Erythema—Epirubicin—breast cancer	9.63e-06	0.00016	CcSEcCtD
Lamivudine—Malnutrition—Epirubicin—breast cancer	9.63e-06	0.00016	CcSEcCtD
Lamivudine—Feeling abnormal—Docetaxel—breast cancer	9.6e-06	0.00016	CcSEcCtD
Lamivudine—Nausea—Fluorouracil—breast cancer	9.59e-06	0.000159	CcSEcCtD
Lamivudine—Ill-defined disorder—Methotrexate—breast cancer	9.54e-06	0.000159	CcSEcCtD
Lamivudine—Gastrointestinal pain—Docetaxel—breast cancer	9.52e-06	0.000158	CcSEcCtD
Lamivudine—Anaemia—Methotrexate—breast cancer	9.51e-06	0.000158	CcSEcCtD
Lamivudine—Flatulence—Epirubicin—breast cancer	9.49e-06	0.000158	CcSEcCtD
Lamivudine—Tension—Epirubicin—breast cancer	9.45e-06	0.000157	CcSEcCtD
Lamivudine—Dysgeusia—Epirubicin—breast cancer	9.43e-06	0.000157	CcSEcCtD
Lamivudine—Diarrhoea—Paclitaxel—breast cancer	9.4e-06	0.000156	CcSEcCtD
Lamivudine—Nervousness—Epirubicin—breast cancer	9.35e-06	0.000155	CcSEcCtD
Lamivudine—Back pain—Epirubicin—breast cancer	9.31e-06	0.000155	CcSEcCtD
Lamivudine—Feeling abnormal—Capecitabine—breast cancer	9.29e-06	0.000154	CcSEcCtD
Lamivudine—Malaise—Methotrexate—breast cancer	9.28e-06	0.000154	CcSEcCtD
Lamivudine—Muscle spasms—Epirubicin—breast cancer	9.25e-06	0.000154	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—breast cancer	9.24e-06	0.000154	CcSEcCtD
Lamivudine—Vertigo—Methotrexate—breast cancer	9.24e-06	0.000154	CcSEcCtD
Lamivudine—Gastrointestinal pain—Capecitabine—breast cancer	9.22e-06	0.000153	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—breast cancer	9.22e-06	0.000153	CcSEcCtD
Lamivudine—Abdominal pain—Docetaxel—breast cancer	9.21e-06	0.000153	CcSEcCtD
Lamivudine—Body temperature increased—Docetaxel—breast cancer	9.21e-06	0.000153	CcSEcCtD
Lamivudine—Leukopenia—Methotrexate—breast cancer	9.21e-06	0.000153	CcSEcCtD
Lamivudine—Chills—Doxorubicin—breast cancer	9.18e-06	0.000153	CcSEcCtD
Lamivudine—Dizziness—Paclitaxel—breast cancer	9.09e-06	0.000151	CcSEcCtD
Lamivudine—Alopecia—Doxorubicin—breast cancer	9.04e-06	0.00015	CcSEcCtD
Lamivudine—Cough—Methotrexate—breast cancer	8.98e-06	0.000149	CcSEcCtD
Lamivudine—Urticaria—Capecitabine—breast cancer	8.96e-06	0.000149	CcSEcCtD
Lamivudine—Ill-defined disorder—Epirubicin—breast cancer	8.93e-06	0.000148	CcSEcCtD
Lamivudine—Abdominal pain—Capecitabine—breast cancer	8.91e-06	0.000148	CcSEcCtD
Lamivudine—Body temperature increased—Capecitabine—breast cancer	8.91e-06	0.000148	CcSEcCtD
Lamivudine—Convulsion—Methotrexate—breast cancer	8.91e-06	0.000148	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—breast cancer	8.91e-06	0.000148	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—breast cancer	8.91e-06	0.000148	CcSEcCtD
Lamivudine—Anaemia—Epirubicin—breast cancer	8.9e-06	0.000148	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—breast cancer	8.78e-06	0.000146	CcSEcCtD
Lamivudine—Chest pain—Methotrexate—breast cancer	8.76e-06	0.000146	CcSEcCtD
Lamivudine—Arthralgia—Methotrexate—breast cancer	8.76e-06	0.000146	CcSEcCtD
Lamivudine—Myalgia—Methotrexate—breast cancer	8.76e-06	0.000146	CcSEcCtD
Lamivudine—Tension—Doxorubicin—breast cancer	8.74e-06	0.000145	CcSEcCtD
Lamivudine—Vomiting—Paclitaxel—breast cancer	8.74e-06	0.000145	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—breast cancer	8.72e-06	0.000145	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	8.7e-06	0.000145	CcSEcCtD
Lamivudine—Malaise—Epirubicin—breast cancer	8.68e-06	0.000144	CcSEcCtD
Lamivudine—Rash—Paclitaxel—breast cancer	8.66e-06	0.000144	CcSEcCtD
Lamivudine—Dermatitis—Paclitaxel—breast cancer	8.66e-06	0.000144	CcSEcCtD
Lamivudine—Discomfort—Methotrexate—breast cancer	8.65e-06	0.000144	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—breast cancer	8.65e-06	0.000144	CcSEcCtD
Lamivudine—Vertigo—Epirubicin—breast cancer	8.65e-06	0.000144	CcSEcCtD
Lamivudine—Syncope—Epirubicin—breast cancer	8.63e-06	0.000143	CcSEcCtD
Lamivudine—Leukopenia—Epirubicin—breast cancer	8.62e-06	0.000143	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—breast cancer	8.62e-06	0.000143	CcSEcCtD
Lamivudine—Headache—Paclitaxel—breast cancer	8.61e-06	0.000143	CcSEcCtD
Lamivudine—Hypersensitivity—Docetaxel—breast cancer	8.58e-06	0.000143	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—breast cancer	8.56e-06	0.000142	CcSEcCtD
Lamivudine—Confusional state—Methotrexate—breast cancer	8.46e-06	0.000141	CcSEcCtD
Lamivudine—Loss of consciousness—Epirubicin—breast cancer	8.46e-06	0.000141	CcSEcCtD
Lamivudine—Cough—Epirubicin—breast cancer	8.4e-06	0.00014	CcSEcCtD
Lamivudine—Anaphylactic shock—Methotrexate—breast cancer	8.39e-06	0.00014	CcSEcCtD
Lamivudine—Asthenia—Docetaxel—breast cancer	8.36e-06	0.000139	CcSEcCtD
Lamivudine—Convulsion—Epirubicin—breast cancer	8.34e-06	0.000139	CcSEcCtD
Lamivudine—Infection—Methotrexate—breast cancer	8.34e-06	0.000139	CcSEcCtD
Lamivudine—Hypersensitivity—Capecitabine—breast cancer	8.31e-06	0.000138	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—breast cancer	8.26e-06	0.000137	CcSEcCtD
Lamivudine—Pruritus—Docetaxel—breast cancer	8.24e-06	0.000137	CcSEcCtD
Lamivudine—Nervous system disorder—Methotrexate—breast cancer	8.23e-06	0.000137	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—breast cancer	8.23e-06	0.000137	CcSEcCtD
Lamivudine—Thrombocytopenia—Methotrexate—breast cancer	8.22e-06	0.000137	CcSEcCtD
Lamivudine—Myalgia—Epirubicin—breast cancer	8.2e-06	0.000136	CcSEcCtD
Lamivudine—Arthralgia—Epirubicin—breast cancer	8.2e-06	0.000136	CcSEcCtD
Lamivudine—Chest pain—Epirubicin—breast cancer	8.2e-06	0.000136	CcSEcCtD
Lamivudine—Anxiety—Epirubicin—breast cancer	8.17e-06	0.000136	CcSEcCtD
Lamivudine—Nausea—Paclitaxel—breast cancer	8.16e-06	0.000136	CcSEcCtD
Lamivudine—Skin disorder—Methotrexate—breast cancer	8.15e-06	0.000136	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.14e-06	0.000135	CcSEcCtD
Lamivudine—Hyperhidrosis—Methotrexate—breast cancer	8.12e-06	0.000135	CcSEcCtD
Lamivudine—Discomfort—Epirubicin—breast cancer	8.1e-06	0.000135	CcSEcCtD
Lamivudine—Asthenia—Capecitabine—breast cancer	8.09e-06	0.000134	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—breast cancer	8.03e-06	0.000133	CcSEcCtD
Lamivudine—Dry mouth—Epirubicin—breast cancer	8.01e-06	0.000133	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—breast cancer	8e-06	0.000133	CcSEcCtD
Lamivudine—Anorexia—Methotrexate—breast cancer	8e-06	0.000133	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—breast cancer	7.99e-06	0.000133	CcSEcCtD
Lamivudine—Pruritus—Capecitabine—breast cancer	7.98e-06	0.000133	CcSEcCtD
Lamivudine—Leukopenia—Doxorubicin—breast cancer	7.97e-06	0.000132	CcSEcCtD
Lamivudine—Diarrhoea—Docetaxel—breast cancer	7.97e-06	0.000132	CcSEcCtD
Lamivudine—Confusional state—Epirubicin—breast cancer	7.92e-06	0.000132	CcSEcCtD
Lamivudine—Anaphylactic shock—Epirubicin—breast cancer	7.86e-06	0.000131	CcSEcCtD
Lamivudine—Oedema—Epirubicin—breast cancer	7.86e-06	0.000131	CcSEcCtD
Lamivudine—Hypotension—Methotrexate—breast cancer	7.84e-06	0.00013	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—breast cancer	7.83e-06	0.00013	CcSEcCtD
Lamivudine—Infection—Epirubicin—breast cancer	7.8e-06	0.00013	CcSEcCtD
Lamivudine—Cough—Doxorubicin—breast cancer	7.77e-06	0.000129	CcSEcCtD
Lamivudine—Shock—Epirubicin—breast cancer	7.73e-06	0.000128	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—breast cancer	7.72e-06	0.000128	CcSEcCtD
Lamivudine—Diarrhoea—Capecitabine—breast cancer	7.72e-06	0.000128	CcSEcCtD
Lamivudine—Nervous system disorder—Epirubicin—breast cancer	7.7e-06	0.000128	CcSEcCtD
Lamivudine—Dizziness—Docetaxel—breast cancer	7.7e-06	0.000128	CcSEcCtD
Lamivudine—Thrombocytopenia—Epirubicin—breast cancer	7.69e-06	0.000128	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Methotrexate—breast cancer	7.65e-06	0.000127	CcSEcCtD
Lamivudine—Skin disorder—Epirubicin—breast cancer	7.63e-06	0.000127	CcSEcCtD
Lamivudine—Hyperhidrosis—Epirubicin—breast cancer	7.59e-06	0.000126	CcSEcCtD
Lamivudine—Insomnia—Methotrexate—breast cancer	7.59e-06	0.000126	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—breast cancer	7.58e-06	0.000126	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—breast cancer	7.58e-06	0.000126	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—breast cancer	7.58e-06	0.000126	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—breast cancer	7.56e-06	0.000126	CcSEcCtD
Lamivudine—Paraesthesia—Methotrexate—breast cancer	7.54e-06	0.000125	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.53e-06	0.000125	CcSEcCtD
Lamivudine—Discomfort—Doxorubicin—breast cancer	7.49e-06	0.000125	CcSEcCtD
Lamivudine—Anorexia—Epirubicin—breast cancer	7.49e-06	0.000124	CcSEcCtD
Lamivudine—Dyspnoea—Methotrexate—breast cancer	7.48e-06	0.000124	CcSEcCtD
Lamivudine—Somnolence—Methotrexate—breast cancer	7.46e-06	0.000124	CcSEcCtD
Lamivudine—Dizziness—Capecitabine—breast cancer	7.46e-06	0.000124	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—breast cancer	7.42e-06	0.000123	CcSEcCtD
Lamivudine—Vomiting—Docetaxel—breast cancer	7.41e-06	0.000123	CcSEcCtD
Lamivudine—Dyspepsia—Methotrexate—breast cancer	7.39e-06	0.000123	CcSEcCtD
Lamivudine—Rash—Docetaxel—breast cancer	7.34e-06	0.000122	CcSEcCtD
Lamivudine—Hypotension—Epirubicin—breast cancer	7.34e-06	0.000122	CcSEcCtD
Lamivudine—Dermatitis—Docetaxel—breast cancer	7.34e-06	0.000122	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—breast cancer	7.33e-06	0.000122	CcSEcCtD
Lamivudine—Decreased appetite—Methotrexate—breast cancer	7.3e-06	0.000121	CcSEcCtD
Lamivudine—Headache—Docetaxel—breast cancer	7.3e-06	0.000121	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—breast cancer	7.27e-06	0.000121	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—breast cancer	7.27e-06	0.000121	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Methotrexate—breast cancer	7.25e-06	0.00012	CcSEcCtD
Lamivudine—Fatigue—Methotrexate—breast cancer	7.24e-06	0.00012	CcSEcCtD
Lamivudine—Infection—Doxorubicin—breast cancer	7.22e-06	0.00012	CcSEcCtD
Lamivudine—Pain—Methotrexate—breast cancer	7.18e-06	0.000119	CcSEcCtD
Lamivudine—Vomiting—Capecitabine—breast cancer	7.17e-06	0.000119	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Epirubicin—breast cancer	7.16e-06	0.000119	CcSEcCtD
Lamivudine—Shock—Doxorubicin—breast cancer	7.15e-06	0.000119	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—breast cancer	7.13e-06	0.000118	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—breast cancer	7.12e-06	0.000118	CcSEcCtD
Lamivudine—Rash—Capecitabine—breast cancer	7.11e-06	0.000118	CcSEcCtD
Lamivudine—Insomnia—Epirubicin—breast cancer	7.11e-06	0.000118	CcSEcCtD
Lamivudine—Dermatitis—Capecitabine—breast cancer	7.1e-06	0.000118	CcSEcCtD
Lamivudine—Headache—Capecitabine—breast cancer	7.06e-06	0.000117	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—breast cancer	7.06e-06	0.000117	CcSEcCtD
Lamivudine—Paraesthesia—Epirubicin—breast cancer	7.05e-06	0.000117	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—breast cancer	7.03e-06	0.000117	CcSEcCtD
Lamivudine—Dyspnoea—Epirubicin—breast cancer	7e-06	0.000116	CcSEcCtD
Lamivudine—Somnolence—Epirubicin—breast cancer	6.98e-06	0.000116	CcSEcCtD
Lamivudine—Anorexia—Doxorubicin—breast cancer	6.93e-06	0.000115	CcSEcCtD
Lamivudine—Nausea—Docetaxel—breast cancer	6.92e-06	0.000115	CcSEcCtD
Lamivudine—Feeling abnormal—Methotrexate—breast cancer	6.92e-06	0.000115	CcSEcCtD
Lamivudine—Dyspepsia—Epirubicin—breast cancer	6.92e-06	0.000115	CcSEcCtD
Lamivudine—Gastrointestinal pain—Methotrexate—breast cancer	6.86e-06	0.000114	CcSEcCtD
Lamivudine—Decreased appetite—Epirubicin—breast cancer	6.83e-06	0.000113	CcSEcCtD
Lamivudine—Hypotension—Doxorubicin—breast cancer	6.79e-06	0.000113	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Epirubicin—breast cancer	6.78e-06	0.000113	CcSEcCtD
Lamivudine—Fatigue—Epirubicin—breast cancer	6.77e-06	0.000113	CcSEcCtD
Lamivudine—Pain—Epirubicin—breast cancer	6.72e-06	0.000112	CcSEcCtD
Lamivudine—Constipation—Epirubicin—breast cancer	6.72e-06	0.000112	CcSEcCtD
Lamivudine—Nausea—Capecitabine—breast cancer	6.7e-06	0.000111	CcSEcCtD
Lamivudine—Urticaria—Methotrexate—breast cancer	6.67e-06	0.000111	CcSEcCtD
Lamivudine—Abdominal pain—Methotrexate—breast cancer	6.64e-06	0.00011	CcSEcCtD
Lamivudine—Body temperature increased—Methotrexate—breast cancer	6.64e-06	0.00011	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—breast cancer	6.62e-06	0.00011	CcSEcCtD
Lamivudine—Insomnia—Doxorubicin—breast cancer	6.57e-06	0.000109	CcSEcCtD
Lamivudine—Paraesthesia—Doxorubicin—breast cancer	6.53e-06	0.000108	CcSEcCtD
Lamivudine—Dyspnoea—Doxorubicin—breast cancer	6.48e-06	0.000108	CcSEcCtD
Lamivudine—Feeling abnormal—Epirubicin—breast cancer	6.47e-06	0.000108	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—breast cancer	6.46e-06	0.000107	CcSEcCtD
Lamivudine—Gastrointestinal pain—Epirubicin—breast cancer	6.42e-06	0.000107	CcSEcCtD
Lamivudine—Dyspepsia—Doxorubicin—breast cancer	6.4e-06	0.000106	CcSEcCtD
Lamivudine—Decreased appetite—Doxorubicin—breast cancer	6.32e-06	0.000105	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—breast cancer	6.28e-06	0.000104	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—breast cancer	6.27e-06	0.000104	CcSEcCtD
Lamivudine—Urticaria—Epirubicin—breast cancer	6.24e-06	0.000104	CcSEcCtD
Lamivudine—Pain—Doxorubicin—breast cancer	6.22e-06	0.000103	CcSEcCtD
Lamivudine—Constipation—Doxorubicin—breast cancer	6.22e-06	0.000103	CcSEcCtD
Lamivudine—Abdominal pain—Epirubicin—breast cancer	6.21e-06	0.000103	CcSEcCtD
Lamivudine—Body temperature increased—Epirubicin—breast cancer	6.21e-06	0.000103	CcSEcCtD
Lamivudine—Hypersensitivity—Methotrexate—breast cancer	6.18e-06	0.000103	CcSEcCtD
Lamivudine—Asthenia—Methotrexate—breast cancer	6.02e-06	0.0001	CcSEcCtD
Lamivudine—Feeling abnormal—Doxorubicin—breast cancer	5.99e-06	9.96e-05	CcSEcCtD
Lamivudine—Gastrointestinal pain—Doxorubicin—breast cancer	5.94e-06	9.88e-05	CcSEcCtD
Lamivudine—Pruritus—Methotrexate—breast cancer	5.94e-06	9.87e-05	CcSEcCtD
Lamivudine—Hypersensitivity—Epirubicin—breast cancer	5.79e-06	9.62e-05	CcSEcCtD
Lamivudine—Urticaria—Doxorubicin—breast cancer	5.77e-06	9.6e-05	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—breast cancer	5.75e-06	9.55e-05	CcSEcCtD
Lamivudine—Body temperature increased—Doxorubicin—breast cancer	5.75e-06	9.55e-05	CcSEcCtD
Lamivudine—Diarrhoea—Methotrexate—breast cancer	5.74e-06	9.55e-05	CcSEcCtD
Lamivudine—Asthenia—Epirubicin—breast cancer	5.64e-06	9.37e-05	CcSEcCtD
Lamivudine—Pruritus—Epirubicin—breast cancer	5.56e-06	9.24e-05	CcSEcCtD
Lamivudine—Dizziness—Methotrexate—breast cancer	5.55e-06	9.23e-05	CcSEcCtD
Lamivudine—Diarrhoea—Epirubicin—breast cancer	5.38e-06	8.93e-05	CcSEcCtD
Lamivudine—Hypersensitivity—Doxorubicin—breast cancer	5.36e-06	8.9e-05	CcSEcCtD
Lamivudine—Vomiting—Methotrexate—breast cancer	5.34e-06	8.87e-05	CcSEcCtD
Lamivudine—Rash—Methotrexate—breast cancer	5.29e-06	8.8e-05	CcSEcCtD
Lamivudine—Dermatitis—Methotrexate—breast cancer	5.29e-06	8.79e-05	CcSEcCtD
Lamivudine—Headache—Methotrexate—breast cancer	5.26e-06	8.74e-05	CcSEcCtD
Lamivudine—Asthenia—Doxorubicin—breast cancer	5.22e-06	8.67e-05	CcSEcCtD
Lamivudine—Dizziness—Epirubicin—breast cancer	5.19e-06	8.63e-05	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—breast cancer	5.14e-06	8.55e-05	CcSEcCtD
Lamivudine—Vomiting—Epirubicin—breast cancer	4.99e-06	8.3e-05	CcSEcCtD
Lamivudine—Nausea—Methotrexate—breast cancer	4.99e-06	8.29e-05	CcSEcCtD
Lamivudine—Diarrhoea—Doxorubicin—breast cancer	4.97e-06	8.27e-05	CcSEcCtD
Lamivudine—Rash—Epirubicin—breast cancer	4.95e-06	8.23e-05	CcSEcCtD
Lamivudine—Dermatitis—Epirubicin—breast cancer	4.95e-06	8.22e-05	CcSEcCtD
Lamivudine—Headache—Epirubicin—breast cancer	4.92e-06	8.18e-05	CcSEcCtD
Lamivudine—Dizziness—Doxorubicin—breast cancer	4.81e-06	7.99e-05	CcSEcCtD
Lamivudine—Nausea—Epirubicin—breast cancer	4.67e-06	7.76e-05	CcSEcCtD
Lamivudine—Vomiting—Doxorubicin—breast cancer	4.62e-06	7.68e-05	CcSEcCtD
Lamivudine—Rash—Doxorubicin—breast cancer	4.58e-06	7.62e-05	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—breast cancer	4.58e-06	7.61e-05	CcSEcCtD
Lamivudine—Headache—Doxorubicin—breast cancer	4.55e-06	7.57e-05	CcSEcCtD
Lamivudine—Nausea—Doxorubicin—breast cancer	4.32e-06	7.18e-05	CcSEcCtD
Lamivudine—ABCG2—Transmembrane transport of small molecules—RAF1—breast cancer	1.02e-06	2.03e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—COMT—breast cancer	1.02e-06	2.03e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.02e-06	2.02e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1B1—breast cancer	1.02e-06	2.02e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTP1—breast cancer	1.02e-06	2.02e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—RAF1—breast cancer	1.01e-06	2.01e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—breast cancer	1.01e-06	2e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HSP90AA1—breast cancer	1.01e-06	2e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1e-06	1.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HMOX1—breast cancer	1e-06	1.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ITPR1—breast cancer	1e-06	1.99e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HSP90AA1—breast cancer	9.97e-07	1.98e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NQO1—breast cancer	9.89e-07	1.96e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC2A1—breast cancer	9.89e-07	1.96e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTHFR—breast cancer	9.85e-07	1.96e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TERT—breast cancer	9.83e-07	1.95e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NCOA1—breast cancer	9.8e-07	1.95e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	9.76e-07	1.94e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	9.74e-07	1.93e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CAV1—breast cancer	9.71e-07	1.93e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NCOA1—breast cancer	9.7e-07	1.93e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CA9—breast cancer	9.67e-07	1.92e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA4—breast cancer	9.67e-07	1.92e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—STK11—breast cancer	9.66e-07	1.92e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP19A1—breast cancer	9.66e-07	1.92e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—breast cancer	9.66e-07	1.92e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP3A4—breast cancer	9.64e-07	1.91e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CG—breast cancer	9.63e-07	1.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ABCB1—breast cancer	9.62e-07	1.91e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—breast cancer	9.58e-07	1.9e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP19A1—breast cancer	9.56e-07	1.9e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—STK11—breast cancer	9.56e-07	1.9e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	9.55e-07	1.9e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGFR1—breast cancer	9.54e-07	1.89e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1B1—breast cancer	9.48e-07	1.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TYMS—breast cancer	9.45e-07	1.88e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—RAF1—breast cancer	9.43e-07	1.87e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPX2—breast cancer	9.43e-07	1.87e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA2—breast cancer	9.43e-07	1.87e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HIF1A—breast cancer	9.4e-07	1.87e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NCOR1—breast cancer	9.34e-07	1.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PLA2G4A—breast cancer	9.34e-07	1.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—breast cancer	9.34e-07	1.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPX4—breast cancer	9.31e-07	1.85e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SULT1A1—breast cancer	9.31e-07	1.85e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HSP90AA1—breast cancer	9.3e-07	1.85e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.28e-07	1.84e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—breast cancer	9.27e-07	1.84e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA1—breast cancer	9.1e-07	1.81e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—IDH1—breast cancer	9.1e-07	1.81e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	9.09e-07	1.8e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CAV1—breast cancer	9.09e-07	1.8e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NCOA1—breast cancer	9.04e-07	1.8e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	9.02e-07	1.79e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NAT2—breast cancer	8.99e-07	1.79e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—COMT—breast cancer	8.98e-07	1.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GPX1—breast cancer	8.94e-07	1.78e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTP1—breast cancer	8.94e-07	1.78e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—STK11—breast cancer	8.91e-07	1.77e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP19A1—breast cancer	8.91e-07	1.77e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—COMT—breast cancer	8.89e-07	1.77e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—breast cancer	8.87e-07	1.76e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1A1—breast cancer	8.85e-07	1.76e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTP1—breast cancer	8.85e-07	1.76e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CG—breast cancer	8.85e-07	1.76e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HMOX1—breast cancer	8.82e-07	1.75e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ITPR1—breast cancer	8.8e-07	1.75e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ERCC2—breast cancer	8.78e-07	1.74e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HMOX1—breast cancer	8.73e-07	1.73e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ITPR1—breast cancer	8.71e-07	1.73e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS2—breast cancer	8.55e-07	1.7e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—breast cancer	8.48e-07	1.68e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOTCH1—breast cancer	8.47e-07	1.68e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ABCB1—breast cancer	8.46e-07	1.68e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CD—breast cancer	8.46e-07	1.68e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ABCB1—breast cancer	8.38e-07	1.66e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—breast cancer	8.35e-07	1.66e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TYMS—breast cancer	8.31e-07	1.65e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—COMT—breast cancer	8.29e-07	1.65e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	8.28e-07	1.64e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KIT—breast cancer	8.28e-07	1.64e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APC—breast cancer	8.28e-07	1.64e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MTHFR—breast cancer	8.25e-07	1.64e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTP1—breast cancer	8.25e-07	1.64e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TYMS—breast cancer	8.23e-07	1.63e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—breast cancer	8.22e-07	1.63e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PLA2G4A—breast cancer	8.22e-07	1.63e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NCOR1—breast cancer	8.22e-07	1.63e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGF—breast cancer	8.18e-07	1.62e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMOX1—breast cancer	8.13e-07	1.61e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NCOR1—breast cancer	8.13e-07	1.61e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PLA2G4A—breast cancer	8.13e-07	1.61e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—breast cancer	8.13e-07	1.61e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ITPR1—breast cancer	8.12e-07	1.61e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	8.01e-07	1.59e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NOS3—breast cancer	7.99e-07	1.59e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MED12—breast cancer	7.89e-07	1.57e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—DPYD—breast cancer	7.89e-07	1.57e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GPX1—breast cancer	7.87e-07	1.56e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—breast cancer	7.83e-07	1.55e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ABCB1—breast cancer	7.81e-07	1.55e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1A1—breast cancer	7.79e-07	1.55e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GPX1—breast cancer	7.79e-07	1.55e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BRAF—breast cancer	7.78e-07	1.54e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CD—breast cancer	7.78e-07	1.54e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDOA—breast cancer	7.76e-07	1.54e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ERCC2—breast cancer	7.72e-07	1.53e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1A1—breast cancer	7.71e-07	1.53e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—breast cancer	7.68e-07	1.52e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TYMS—breast cancer	7.67e-07	1.52e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ERCC2—breast cancer	7.65e-07	1.52e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CAV1—breast cancer	7.61e-07	1.51e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—breast cancer	7.58e-07	1.5e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PLA2G4A—breast cancer	7.58e-07	1.5e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NCOR1—breast cancer	7.58e-07	1.5e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT2—breast cancer	7.57e-07	1.5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOA3—breast cancer	7.54e-07	1.5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A2—breast cancer	7.48e-07	1.49e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CB—breast cancer	7.38e-07	1.46e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NOS3—breast cancer	7.35e-07	1.46e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CPT1A—breast cancer	7.33e-07	1.46e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTR—breast cancer	7.33e-07	1.46e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ABCG2—breast cancer	7.33e-07	1.46e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—breast cancer	7.31e-07	1.45e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CD—breast cancer	7.28e-07	1.44e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.27e-07	1.44e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MTHFR—breast cancer	7.26e-07	1.44e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GPX1—breast cancer	7.26e-07	1.44e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SERPINE1—breast cancer	7.2e-07	1.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HPGDS—breast cancer	7.19e-07	1.43e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MTHFR—breast cancer	7.19e-07	1.43e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1A1—breast cancer	7.18e-07	1.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HBA1—breast cancer	7.15e-07	1.42e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ERCC2—breast cancer	7.13e-07	1.41e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—breast cancer	7.12e-07	1.41e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTT1—breast cancer	6.97e-07	1.38e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ACHE—breast cancer	6.97e-07	1.38e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CG—breast cancer	6.93e-07	1.38e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS3—breast cancer	6.87e-07	1.36e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CB—breast cancer	6.78e-07	1.35e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	6.77e-07	1.34e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—breast cancer	6.72e-07	1.33e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MTHFR—breast cancer	6.7e-07	1.33e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CAV1—breast cancer	6.7e-07	1.33e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CAV1—breast cancer	6.63e-07	1.32e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP17A1—breast cancer	6.6e-07	1.31e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS1—breast cancer	6.53e-07	1.3e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ENO1—breast cancer	6.53e-07	1.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MDM2—breast cancer	6.52e-07	1.29e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RAF1—breast cancer	6.5e-07	1.29e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—breast cancer	6.43e-07	1.28e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2D6—breast cancer	6.41e-07	1.27e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—breast cancer	6.37e-07	1.27e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CB—breast cancer	6.34e-07	1.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTOR—breast cancer	6.34e-07	1.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD4—breast cancer	6.33e-07	1.26e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOA2—breast cancer	6.29e-07	1.25e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—breast cancer	6.29e-07	1.25e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CAV1—breast cancer	6.18e-07	1.23e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	6.11e-07	1.21e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CG—breast cancer	6.1e-07	1.21e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—FASN—breast cancer	6.1e-07	1.21e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CD—breast cancer	6.1e-07	1.21e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BCHE—breast cancer	6.08e-07	1.21e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CG—breast cancer	6.04e-07	1.2e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—breast cancer	6.02e-07	1.19e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC5A5—breast cancer	6e-07	1.19e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1B—breast cancer	5.95e-07	1.18e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—breast cancer	5.86e-07	1.16e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—breast cancer	5.82e-07	1.15e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC2A1—breast cancer	5.8e-07	1.15e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NQO1—breast cancer	5.8e-07	1.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NOS3—breast cancer	5.76e-07	1.14e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP3A4—breast cancer	5.65e-07	1.12e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CG—breast cancer	5.63e-07	1.12e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CTNNB1—breast cancer	5.62e-07	1.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1B1—breast cancer	5.56e-07	1.1e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	5.53e-07	1.1e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1A—breast cancer	5.49e-07	1.09e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—breast cancer	5.48e-07	1.09e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HSP90AA1—breast cancer	5.45e-07	1.08e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CD—breast cancer	5.36e-07	1.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CB—breast cancer	5.31e-07	1.05e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CD—breast cancer	5.31e-07	1.05e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOA1—breast cancer	5.3e-07	1.05e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—breast cancer	5.29e-07	1.05e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—breast cancer	5.26e-07	1.05e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—breast cancer	5.24e-07	1.04e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—STK11—breast cancer	5.22e-07	1.04e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP19A1—breast cancer	5.22e-07	1.04e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SRC—breast cancer	5.08e-07	1.01e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NOS3—breast cancer	5.06e-07	1.01e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NOS3—breast cancer	5.01e-07	9.95e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CD—breast cancer	4.95e-07	9.82e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—breast cancer	4.9e-07	9.73e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—breast cancer	4.88e-07	9.7e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—COMT—breast cancer	4.86e-07	9.64e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTP1—breast cancer	4.83e-07	9.6e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMOX1—breast cancer	4.77e-07	9.47e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ITPR1—breast cancer	4.76e-07	9.44e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK3—breast cancer	4.68e-07	9.3e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CB—breast cancer	4.67e-07	9.28e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NOS3—breast cancer	4.67e-07	9.27e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—breast cancer	4.63e-07	9.2e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CB—breast cancer	4.63e-07	9.19e-06	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—breast cancer	4.59e-07	9.11e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—breast cancer	4.58e-07	9.1e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—breast cancer	4.56e-07	9.04e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—breast cancer	4.54e-07	9.02e-06	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—breast cancer	4.5e-07	8.93e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TYMS—breast cancer	4.49e-07	8.92e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—breast cancer	4.46e-07	8.85e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOR1—breast cancer	4.44e-07	8.82e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLA2G4A—breast cancer	4.44e-07	8.82e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—breast cancer	4.44e-07	8.82e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CB—breast cancer	4.31e-07	8.56e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—breast cancer	4.27e-07	8.48e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GPX1—breast cancer	4.25e-07	8.45e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1A1—breast cancer	4.21e-07	8.36e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—breast cancer	4.21e-07	8.36e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ERCC2—breast cancer	4.18e-07	8.29e-06	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—breast cancer	4.13e-07	8.21e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—breast cancer	4.04e-07	8.02e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—breast cancer	4e-07	7.94e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTHFR—breast cancer	3.93e-07	7.79e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—breast cancer	3.87e-07	7.68e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—breast cancer	3.73e-07	7.4e-06	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—breast cancer	3.67e-07	7.29e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CAV1—breast cancer	3.62e-07	7.19e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—breast cancer	3.58e-07	7.1e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—breast cancer	3.42e-07	6.8e-06	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—breast cancer	3.38e-07	6.7e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CG—breast cancer	3.3e-07	6.55e-06	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—breast cancer	3.24e-07	6.43e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—breast cancer	3.16e-07	6.27e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CD—breast cancer	2.9e-07	5.76e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—breast cancer	2.86e-07	5.68e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—breast cancer	2.85e-07	5.66e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—breast cancer	2.82e-07	5.6e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NOS3—breast cancer	2.74e-07	5.44e-06	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—breast cancer	2.65e-07	5.25e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—breast cancer	2.63e-07	5.22e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CB—breast cancer	2.53e-07	5.02e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—breast cancer	2.5e-07	4.97e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—breast cancer	2.33e-07	4.62e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—breast cancer	2.3e-07	4.57e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—breast cancer	2.18e-07	4.34e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—breast cancer	2.15e-07	4.26e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—breast cancer	1.54e-07	3.06e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—breast cancer	1.26e-07	2.5e-06	CbGpPWpGaD
